Oncorus raises $80M for 2-front oncolytic virus R&D push

Oncorus raises $80M for 2-front oncolytic virus R&D push

Source: 
Fierce Biotech
snippet: 

Oncorus has raised $79.5 million to advance oncolytic viruses. The series B round equips Oncorus to move its lead prospect into the clinic and nominate an intravenously administered viral candidate early next year.